Krystal Biotech, Inc. (KRYS) came out with quarterly earnings of $1.29 per share, beating the Zacks Consensus Estimate of$1.08 per share. This compares to earnings of $0.86 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +19.44$1.38 per share when it actually produced earnings of $1.2, delivering a surprise of -13.04%.Over the last four quarters, the c ...